World

No, Pfizer and Novavax vaccines are not the same. Here are all major companies involved in developing COVID-19 vaccine

As it stands, no country has ordered more vaccine doses than India with 1.6 billion. Here is everything you need to know about developments in the vaccine race against the coronavirus.
Pfizer-Biontech: The dosage consists of two shots 21 days apart. Trials showed it is approximately 95% effective. (Photo | AFP)
Pfizer-Biontech: The dosage consists of two shots 21 days apart. Trials showed it is approximately 95% effective. (Photo | AFP)
Express News Service
Updated on: 
2 min read
The one big potential problem of this vaccine is that it can be stored at temperature levels below -70 degree celsius. The research first began as early as 11 months ago when Covid-19 wasn’t even declared a pandemic. (Photo | AP)
The one big potential problem of this vaccine is that it can be stored at temperature levels below -70 degree celsius. The research first began as early as 11 months ago when Covid-19 wasn’t even declared a pandemic. (Photo | AP)
AstraZeneca-Oxford: Two doses a month apart, with trials showing different efficacy results (people who had received a half first dose had 90% efficacy while the ones who had received the full dose had 62%) but this wasn’t the plan. Late-stage trial numbers expected within the next month. (Photo | AFP)
AstraZeneca-Oxford: Two doses a month apart, with trials showing different efficacy results (people who had received a half first dose had 90% efficacy while the ones who had received the full dose had 62%) but this wasn’t the plan. Late-stage trial numbers expected within the next month. (Photo | AFP)
AstraZeneca's vaccine can be stored in a refrigerator for six months. Known as Covidshield in India, the Serum Institute of India did apply to the Indian government for Emergency Use Authorisation. Likely to be cheap and because it’s easy to store, most of the developing world have hung on their hat on the efficacy of this vaccine.
AstraZeneca's vaccine can be stored in a refrigerator for six months. Known as Covidshield in India, the Serum Institute of India did apply to the Indian government for Emergency Use Authorisation. Likely to be cheap and because it’s easy to store, most of the developing world have hung on their hat on the efficacy of this vaccine.
Novavax: Two doses, three weeks apart. Trials for a Covid-19 vaccine began in May, with initial numbers proving to be good. Numbers from ongoing Phase 3 trials in a few countries expected to come in the first quarter of 2021. (Photo | AFP)
Novavax: Two doses, three weeks apart. Trials for a Covid-19 vaccine began in May, with initial numbers proving to be good. Numbers from ongoing Phase 3 trials in a few countries expected to come in the first quarter of 2021. (Photo | AFP)
What’s of interest is that the US-based company have already entered into a huge agreement with Serum Institute of India for the production of as many 2 billion doses by 2021 end. (Photo | AFP)
What’s of interest is that the US-based company have already entered into a huge agreement with Serum Institute of India for the production of as many 2 billion doses by 2021 end. (Photo | AFP)
Gamaleya's Sputnik V: Two shots, three weeks apart. Came out with a statement on Monday which put their efficacy at 91.4%. Clinical trials began in June. Has to be stored in a freezer. (Photo | AFP)
Gamaleya's Sputnik V: Two shots, three weeks apart. Came out with a statement on Monday which put their efficacy at 91.4%. Clinical trials began in June. Has to be stored in a freezer. (Photo | AFP)
Johnson & Johnson: A one-shot vaccine at this point, with trials launched back in September. Will have a potential advantage over other developers if their one-shot jab works because of the ease of storage plus it requires only one shot. Phase 3 trials were paused to investigate an adverse reaction in October. Phase 3 results are expected in January. (Photo | AP)
Johnson & Johnson: A one-shot vaccine at this point, with trials launched back in September. Will have a potential advantage over other developers if their one-shot jab works because of the ease of storage plus it requires only one shot. Phase 3 trials were paused to investigate an adverse reaction in October. Phase 3 results are expected in January. (Photo | AP)
Moderna: Two dosages split by a month. Trials showed an over 94% efficacy rate. Is expected to receive nod for emergency use authorisation in the US in a few days. (Photo | AFP)
Moderna: Two dosages split by a month. Trials showed an over 94% efficacy rate. Is expected to receive nod for emergency use authorisation in the US in a few days. (Photo | AFP)
WHAT IS COVAX?: Covax is an initiative to ensure that poor countries have access to vaccines at an accessible rate.(Photo | AP)
WHAT IS COVAX?: Covax is an initiative to ensure that poor countries have access to vaccines at an accessible rate.(Photo | AP)
WHO HAS ORDERED THE MOST?: As it stands, no country has ordered more vaccine doses than India with 1.6 billion. (Photo | AP)
WHO HAS ORDERED THE MOST?: As it stands, no country has ordered more vaccine doses than India with 1.6 billion. (Photo | AP)
HOW MANY STAGES BEFOFE ROLLOUT?: Usually, the vaccine has six stages from the time of research to full approval. The first is preclinical testing before the three phases of trials — Phase 1, Phase 2 and Phase 3 — finish. (Photo | AP)
HOW MANY STAGES BEFOFE ROLLOUT?: Usually, the vaccine has six stages from the time of research to full approval. The first is preclinical testing before the three phases of trials — Phase 1, Phase 2 and Phase 3 — finish. (Photo | AP)
In the interim, if the results for the trials are out and if the regulators like the numbers, they will sanction Emergency Use Authorisation for the vaccine. It’s where the likes of the PfizerBioNTech vaccine are at this stage. After this, countries decide to give full approval for mass inoculation. (Photo | AP)
In the interim, if the results for the trials are out and if the regulators like the numbers, they will sanction Emergency Use Authorisation for the vaccine. It’s where the likes of the PfizerBioNTech vaccine are at this stage. After this, countries decide to give full approval for mass inoculation. (Photo | AP)
Coronavirus
COVID-19
COVID vaccine
Novavax
Covaxin
Pfizer
COVAX

Related Stories

No stories found.
The New Indian Express
www.newindianexpress.com